We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+16.93%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$2.62B
AUM Growth
+$228M
Cap. Flow
-$80.2M
Cap. Flow %
-3.06%
Top 10 Hldgs %
60.62%
Holding
146
New
15
Increased
46
Reduced
40
Closed
14

Top Buys

Rank Stock Value
1
STNG icon
Scorpio Tankers
STNG
+$45.3M
2
MU icon
Micron Technology
MU
+$35.2M
3
CCJ icon
Cameco
CCJ
+$28.2M
4
ZTO icon
ZTO Express
ZTO
+$23.4M
5
PBR icon
Petrobras
PBR
+$17.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.06%
2 Industrials 20.17%
3 Technology 17.4%
4 Healthcare 12.65%
5 Energy 11.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFMD
101
DELISTED
Affimed
AFMD
$718K 0.03%
57,913
ABSI icon
102
Absci
ABSI
$1.53B
$667K 0.03%
317,772
XGN icon
103
Exagen
XGN
$161M
$634K 0.02%
264,130
-86,941
-25% -$223K
ORCL icon
104
Oracle
ORCL
$435B
$610K 0.02%
7,459
CYPH
105
Cypherpunk Technologies Inc
CYPH
$72.4M
$598K 0.02%
132,795
CSCO icon
106
Cisco
CSCO
$483B
$597K 0.02%
12,535
-8,891
-41% -$405K
INFI
107
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$303K 0.01%
545,508
CLB icon
108
Core Laboratories
CLB
$561M
$286K 0.01%
14,130
-1,825
-11% -$35.4K
INTC icon
109
Intel
INTC
$492B
$282K 0.01%
10,664
+2,324
+28% +$64.5K
BALL icon
110
Ball Corp
BALL
$16.6B
$158K 0.01%
3,082
+658
+27% +$34.1K
CHTR icon
111
Charter Communications
CHTR
$18.3B
$143K 0.01%
+422
New +$148K
CCK icon
112
Crown Holdings
CCK
$13.1B
$122K ﹤0.01%
+1,490
New +$119K
UHS icon
113
Universal Health Services
UHS
$10.5B
$99.8K ﹤0.01%
708
-121
-15% -$14.3K
HCA icon
114
HCA Healthcare
HCA
$89.6B
$96.2K ﹤0.01%
401
HBI
115
DELISTED
Hanesbrands
HBI
$95K ﹤0.01%
14,936
+7,239
+94% +$49.7K
CI icon
116
Cigna
CI
$73.6B
$94.8K ﹤0.01%
286
-10
-3% -$3.16K
CTSH icon
117
Cognizant
CTSH
$26.3B
$93K ﹤0.01%
+1,626
New +$95.4K
KMX icon
118
CarMax
KMX
$8.34B
$92.8K ﹤0.01%
+1,524
New +$97.8K
RL icon
119
Ralph Lauren
RL
$24.2B
$92.5K ﹤0.01%
+875
New +$87.6K
CRC icon
120
California Resources
CRC
$4.77B
$89.4K ﹤0.01%
2,055
+42
+2% +$1.84K
MOMO
121
Hello Group
MOMO
$870M
$88.6K ﹤0.01%
9,871
BBY icon
122
Best Buy
BBY
$17.4B
$88.2K ﹤0.01%
1,099
-9
-0.8% -$662
OMF icon
123
OneMain Financial
OMF
$7.27B
$83.7K ﹤0.01%
2,513
+325
+15% +$11.5K
T icon
124
AT&T
T
$165B
$83.3K ﹤0.01%
4,524
+158
+4% +$2.83K
ALSN icon
125
Allison Transmission
ALSN
$10.3B
$81K ﹤0.01%
1,946
-365
-16% -$15K

Similar funds

Platinum Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Platinum Investment Management held 146 positions worth $2.62B, up 9.5% from $2.4B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Platinum Investment Management withdrew a net $80.2M in Q4 2022, closing 14 positions and reducing 40 holdings. Its most notable exit was BTRS Holdings Inc. Class 1 Common Stock, an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

Against the trend, Platinum Investment Management opened a new position in Scorpio Tankers worth $48.8M.

  • Platinum Investment Management's largest Q4 2022 buy was Scorpio Tankers: 907,421 shares worth $48.8M.
  • Platinum Investment Management added most to Micron Technology in Q4 2022, an estimated $35.2M increase.
  • Platinum Investment Management's biggest Q4 2022 reduction was The Mosaic Company, cutting an estimated $75.8M.
  • Platinum Investment Management fully exited BTRS Holdings Inc. Class 1 Common Stock in Q4 2022, selling an estimated $27.7M.
  • Platinum Investment Management's ten largest holdings make up 61% of its $2.62B portfolio in Q4 2022.
  • Platinum Investment Management opened 15 new positions and closed 14 in Q4 2022.
  • Platinum Investment Management's portfolio value rose 9.5% quarter-over-quarter to $2.62B.

Based on Platinum Investment Management's 13F filing for Q4 2022, filed 13 Feb 2023.